TREATMENT WITH LISINOPRIL NORMALIZES SERUM CONCENTRATIONS OF PROCOLLAGEN TYPE-III AMINO-TERMINAL PEPTIDE IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引:35
作者
LAVIADES, C [1 ]
MAYOR, G [1 ]
DIEZ, J [1 ]
机构
[1] SAN JORGE GEN HOSP,DEPT MED,HUESCA,SPAIN
关键词
ESSENTIAL HYPERTENSION; COLLAGEN TYPE; LISINOPRIL;
D O I
10.1093/ajh/7.1.52
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Procollagen type III amino-terminal peptide (PIIIP) is cleaved off procollagen type III during the biosynthesis of type III collagen. Thus, to assess the synthesis of collagen type III in essential hypertension, we determined the serum concentrations of PIIIP in 24 patients with never-treated essential hypertension and in 30 normotensive controls. In addition, serum concentrations of PIIIP were measured in 15 patients after receiving lisinopril during 6 months. Serum PIIIP was higher in hypertensives than controls (11.20 +/- 0.76 v 8.47 +/- 0.77 ng/mt, mean +/- SEM, P <.01). A direct correlation was found between serum PIIIP and plasma renin activity (r = 0.54, P <.01) in the group of hypertensives. In addition, serum PIIIP was correlated inversely with maximal early transmitral flow velocity measured during diastole by Doppler echocardiography (r = -0.74, P <.001) in the group of hypertensive patients. The serum PIIIP levels de-creased significantly in patients treated with lisinopril (11.76 +/- 0.84 v 8.47 +/- 0.66 ng/mL, P <.01). A significant increase of plasma renin activity and a significant decrease of plasma aldosterone was observed in these patients after treatment with lisinopril. These results suggest that increased collagen type III synthesis is present in patients with essential hypertension. Abnormal synthesis of collagen type III in essential hypertension may be related to the activity of circulating renin-angiotens in-aldosterone system. Whether an excessive synthesis of myocardial collagen type III is responsible for increased serum PIIIP present in essential hypertension deserves further investigation.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 42 条
[1]  
Doering C.W., Jalil J.E., Janicki J.S., Et al., Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy, Cardiovasc Res, 22, pp. 686-695, (1988)
[2]  
Michel J.B., Salzmann J.L., Carol M.L., Et al., Myocardial effect of converting enzyme inhibition in hypertensive and normotensive rats, Am J Med, 84, pp. A12-A21, (1988)
[3]  
Jalil J.E., Doering C.W., Janicki J.S., Et al., Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle, Circ Res, 64, pp. 1041-1050, (1989)
[4]  
Pfeffer J.M., Pfeffer M.A., Fishbein M.C., Frohlich E.D., Cardiac function and morphology with aging in the spontaneously hypertensive rat, Am J Physiol, 6, pp. H461-H468, (1979)
[5]  
Pick R., Janicki J.S., Weber K.T., Myocardial fibrosis in nonhuman primate with pressure overload hypertrophy, Am J Pathol, 135, pp. 771-781, (1989)
[6]  
Weber K.T., Janicki J.S., Pick R., Et al., Collagen in the hypertrophied pressure-overloaded myocardium, Circulation, 75, pp. 40-47, (1986)
[7]  
Abrahams C., Janicki J.S., Weber K.T., Myocardial hypertrophy in Macaca fascicularis: Structural remodeling of the collagen matrix, Lab Invest, 56, pp. 676-683, (1987)
[8]  
Anderson K.R., St John Sutton M.G., Lie J.T., Histo-pathological types of cardiac fibrosis in myocardial disease, J Pathol, 128, pp. 79-85, (1979)
[9]  
Pearlman E.S., Weber K.T., Janicki J.S., Et al., Muscle fiber orientation and connective tissue content in the hypertrophied human heart, Lab Invest, 46, pp. 158-164, (1982)
[10]  
Huysman J., Vliegen H.W., Vanderlaarse A., Eulderink F., Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophied human hearts, Pathol Res Pract, 184, pp. 577-581, (1989)